SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH M impact

ANI Pharmaceuticals raises 2026 adjusted EPS view to $9.37–$9.71

ANIP
SquawkNews Desk 2 updates Updated Nov 05, 2026, 12:05 PM UTC

Story updates

11:54:57 AM UTC
SquawkNews
*--GUIDANCE: (ANIP) ANI Pharmaceuticals Expects 2026 Adjusted EPS Range $9.37 - $9.71, vs. FactSet Est of $9.27

Related stories

DTE Energy Confirms 2026 Operating EPS Guidance of $7.59-$7.73 M impact | EARNINGS | Nov 05, 2026, 12:05 PM UTC ANI Pharmaceuticals Reports Third-Quarter Revenue of $290.8 Million M impact | EQUITY | Nov 05, 2026, 11:58 AM UTC Wheels Up Experience Reports 3Q Loss per Share of $2.48 M impact | EARNINGS | Nov 05, 2026, 11:57 AM UTC Volkswagen Forecasts Full-Year Operating Margin of Up to 1% Volkswagen forecasts a full-year reported operating margin of up to 1%. M impact | EARNINGS | Nov 05, 2026, 11:57 AM UTC Volkswagen Sees 2026 Operating Margin Up to 1% Volkswagen expects an operating margin of up to 1% in 2026. M impact | EARNINGS | Nov 05, 2026, 11:57 AM UTC Becton Dickinson Expects Fiscal 2027 Adjusted EPS of $13.10–$13.30 Becton Dickinson expects fiscal 2027 adjusted EPS of $13.10 to $13.30, versus a FactSet estimate of $13.25. M impact | EARNINGS | Nov 05, 2026, 11:56 AM UTC